tiprankstipranks

Sarah Romano Insider Profile

4 Followers
Sarah Romano, CFO at Kiora Pharmaceuticals, holds 18.01K shares in Entero Therapeutics (Ticker: ENTO), holds 22.75K shares in Kiora Pharmaceuticals (Ticker: KPRX). Most recently, Sarah Romano Sold ― shares of Entero Therapeutics on Oct 10, 2024 for an estimated value of 209.44.
tipranks
Sarah Romano

Sarah Romano
Kiora Pharmaceuticals (KPRX)
CFO

Ranked #3,468 out of 99,335 Corporate Insiders

Profitable Transactions

70%
7 out of 10 Profitable Transactions

Average Return

+40.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$85K
90.38%
9.62%
A breakdown of Sarah Romano's holdings

Insider Roles

Kiora Pharmaceuticals
(KPRX)
CFO
Entero Therapeutics
(ENTO)
CFO
Roles that Sarah Romano holds in companies

Most Profitable Insider Trade

Stock:
Entero Therapeutics
(ENTO)
Rating:Informative Sell
Date:Jul 05, 2023 - Jul 05, 2024
Return:+96.40%
The most profitable trade made by Sarah Romano

Sarah Romano's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kiora Pharmaceuticals
Feb 11, 2022
CFO
Uninformative Sell
74.52
$76.63K
Entero Therapeutics
Oct 10, 2024
CFO
Informative Sell
209.44
$8.16K
List of latest transactions for each holding click on a transaction to see Sarah Romano's performance on stock

Sarah Romano insider profile FAQ

What is the percentage of profitable transactions made by Sarah Romano?
The percentage of profitable transactions made by Sarah Romano is 70%.
    What is the average return per transaction made by Sarah Romano?
    The average return per transaction made by Sarah Romano is 40.40%.
      What stocks does Sarah Romano hold?
      Sarah Romano holds: KPRX, ENTO stocks.
        What was Sarah Romano’s latest transaction?
        Sarah Romano latest transaction was an Informative Sell of $209.44.
          What was Sarah Romano's most profitable transaction?
          Sarah Romano’s most profitable transaction was an Informative Sell of ENTO stock on July 5, 2023. The return on the trade was 96.40%.
            What is Sarah Romano's role in Kiora Pharmaceuticals?
            Sarah Romano's role in Kiora Pharmaceuticals is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.